Morning Headlines 2/22/23
February 21, 2023 Headlines No Comments AGS Acquires Offshore Patient Access BPO Unit from Availity
AGS Health acquires the India-based patient access outsourcing business of Availity, which adds 200 team members to AGS…
February 21, 2023 Headlines No Comments AGS Acquires Offshore Patient Access BPO Unit from Availity
AGS Health acquires the India-based patient access outsourcing business of Availity, which adds 200 team members to AGS…
What You Should Know:– AGS Health, a provider for tech-enabled revenue cycle management (RCM) solutions announces the acquisition of the India-based patient access outsourcing business unit of the Florida-based healthcare technology company Availity.– With more…
Continue ReadingThe following is a guest article by John Gaede, Director of Information Systems at Sky Lakes Medical Center.
Imagine a rural business is the victim of a cyberattack. A nefarious person or group convinces an…
The following is a guest article by Chris Menier, President of VIA AIOPS at Vitria Technology.
For healthcare providers and payers, improving the experience of members and patients requires replacing disconnected legacy systems with agile…
Sachin Agrawal, MSc is CEO of EVisit of Mesa, AZ.
Tell me about yourself and the company.
I’ve been in healthcare consulting and software for 20 years, always focused on the enterprise needs…
Harness the true power of the data!
Yes. That’s the ultimate goal of Business intelligence (BI).
BI has the potential to unlock endless possibilities for the healthcare industry to thrive.
In other words, data is evolving as a new diagnostic tool in healthcare.
That’s the reason, healthcare organizations, startups, enterprises, and individuals are…
South Korean medical AI company Lunit has announced its decision to establish a wholly-owned subsidiary in Europe.According to a press release, Lunit Europe Holdings will be based in Amsterdam in the Netherlands and will begin local staff recruitment shortly.
WHY IT MATTERS
Although Lunit had a branch office which previously managed its European business, its subsidiary in the continent will allow it to plan for the expansion of its sales network and fortify existing partnerships there.
According to data from Statista, the European medical device market is expected to be worth $136 billion this year. Its biggest segment is cardiology devices with a projected…
Pharmacy Benefit Managers (PBMs) took a hit from lawmakers during a Thursday hearing held by the Senate Commerce Committee, with some questioning why the drug middlemen are even necessary.
“The way I see the situation on PBMs, I don’t know why the hell they even exist,” said Sen. Jon Tester, D-Montana. “They were set up with all the right reasons … But what I see them doing in my state, I don’t think the consumer gets much benefit and they’re shutting down small businesses on main street right and left and those are called our local neighborhood pharmacies.” The hearing discussed how…
At a recent conference, I had a chance to chat with Atul Singh, General Manager, Digital Health at LG Electronics about their relatively recent virtual care solution with Amwell. It makes a lot of sense why Amwell and LG would want to work together. Many hospitals and healthcare organizations have already installed LG TVs in their organizations or they will as they build new hospitals or update their existing exam rooms. Those TVs often act as a hub of information for a patient and increasingly are becoming a patients connection with their nurses and doctors.Given that final piece, LG and Amwell…
Continue ReadingGrifols, a company that turns blood plasma into therapies for immunological disorders and other conditions, is laying off about 2,000 U.S. workers as part of a corporate restructuring projected to yield up to €400 million in annual cost savings, the biotech announced Wednesday.
The layoffs represent about 8% of the Barcelona-based company’s global workforce, but they will happen mainly in its U.S. plasma operations. That’s notable because as a company that relies on plasma, the U.S. is vital to its business. The starting point for Grifols’s therapies is blood plasma. Key to its drug-making process is fractionation, in which the protein components…